These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin]. He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357 [TBL] [Abstract][Full Text] [Related]
11. Transferrin-bearing polypropylenimine dendrimer for targeted gene delivery to the brain. Somani S; Blatchford DR; Millington O; Stevenson ML; Dufès C J Control Release; 2014 Aug; 188():78-86. PubMed ID: 24933602 [TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma. Wang K; Kievit FM; Jeon M; Silber JR; Ellenbogen RG; Zhang M Adv Healthc Mater; 2015 Dec; 4(17):2719-26. PubMed ID: 26498165 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11. Ray S; Almasan A Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654 [TBL] [Abstract][Full Text] [Related]
15. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708 [TBL] [Abstract][Full Text] [Related]
16. Targeted radiotherapy potentiates the cytotoxicity of a novel anti-human DR5 monoclonal antibody and the adenovirus encoding soluble TRAIL in prostate cancer. Arafat W; Zhou T; Naoum GE; Buchsbaum DJ J Egypt Natl Canc Inst; 2015 Dec; 27(4):205-15. PubMed ID: 26385392 [TBL] [Abstract][Full Text] [Related]
17. Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors. Oh Y; Swierczewska M; Kim TH; Lim SM; Eom HN; Park JH; Na DH; Kim K; Lee KC; Pomper MG; Lee S J Control Release; 2015 Dec; 220(Pt B):671-81. PubMed ID: 26381901 [TBL] [Abstract][Full Text] [Related]
18. MiRNA regulation of TRAIL expression exerts selective cytotoxicity to prostate carcinoma cells. Huo W; Jin N; Fan L; Wang W Mol Cell Biochem; 2014 Mar; 388(1-2):123-33. PubMed ID: 24292881 [TBL] [Abstract][Full Text] [Related]
19. Synergistic action of lactoferrin in enhancing the safety and effectiveness of docetaxel treatment against prostate cancer. Muj C; Mukhopadhyay S; Jana P; Kondapi AK Cancer Chemother Pharmacol; 2023 May; 91(5):375-387. PubMed ID: 36977771 [TBL] [Abstract][Full Text] [Related]
20. Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells. Liu Y; Chen L; Gong Z; Shen L; Kao C; Hock JM; Sun L; Li X Oncotarget; 2015 Feb; 6(5):3055-70. PubMed ID: 25605010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]